UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000043865
Receipt number R000050068
Scientific Title Evaluation of health-related quality of life and physical activity in patients undergoing radical endometrial cancer
Date of disclosure of the study information 2021/04/08
Last modified on 2024/04/10 12:35:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of health-related quality of life and physical activity in patients undergoing radical endometrial cancer

Acronym

Evaluation of health-related quality of life in patients undergoing radical endometrial cancer

Scientific Title

Evaluation of health-related quality of life and physical activity in patients undergoing radical endometrial cancer

Scientific Title:Acronym

Evaluation of health-related quality of life in patients undergoing radical endometrial cancer

Region

Japan


Condition

Condition

cancer

Classification by specialty

Obstetrics and Gynecology Rehabilitation medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The purpose is to explore changes in health-related quality of life over time from postoperative to 12 months after surgery for endometrial cancer patients, and to clarify factors related to health-related quality of life.

Basic objectives2

Others

Basic objectives -Others

To conduct a questionnaire survey using a self-administered questionnaire on health-related quality of life and amount of activity in daily life of endometrial cancer patients from postoperative to 12 months postoperative, and to explore changes over time. To clarify the relationship between health-related quality of life and the amount of physical activity.

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Evaluation period: Postoperative, 6 months postoperative, 12 months postoperative

Outcome: Health-related quality of life scale (The European Organization for Research and Treatment of Cancer QLQ-C30)

Key secondary outcomes

Evaluation period:
Postoperative, 6 monts postoperative, 12months postoperative

Outcomes:
1 Health-related quality of life for endometria cancer (The European Organaization for Research and Treatment of Cancer QOL EN24)
2 Ovarian deficiency symptom scale ( The Keio Questionnaire)
3 Physical activity scale (International standardized physical activity questionnaire)


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

1 Cases pathologically diagnosed with endometrial cancer
2 From the date of approval by the Ethics Committees, patients who underwent surgery including total hysterectomy + bilateral adnexectomy as the initial treatment for endometrial cancer at keio University Hospital Gynecology
3 Cases over 20 years old
4 Cases that can be explained and understood in writing and signed with consent
5 Symptoms that are expected to be able to read the mailed questionnaire, create an answer, and reply.

Key exclusion criteria

1 Cases with active double cancer
2 Cases with a history of cancer within 5 years other than carcinoma in situ
3 Cases with a history of serious mental illness or complications
4 Cases in whch walking is not independent
5 Cases that require assistance in daily life

Target sample size

110


Research contact person

Name of lead principal investigator

1st name Aiko
Middle name
Last name Ishikawa

Organization

Keio University school of medicine

Division name

Rehabilitation medicine

Zip code

160-0016

Address

35 Shinanomachi Shinjyuku-ku, Tokyo

TEL

03-5363-3833

Email

aishi@keio.jp


Public contact

Name of contact person

1st name Kiriko
Middle name
Last name Abe

Organization

Keio University school of medicine

Division name

Rehabilitation medicine

Zip code

160-0016

Address

35 Shinanomachi Shinjyuku-ku, Tokyo

TEL

03-5363-3833

Homepage URL


Email

kiriko916@keio.jp


Sponsor or person

Institute

Department of Rehabilitaion medicine, Keio University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Keio University Facultory of Medicine Ethics Committee

Address

35 Shinanomachi Shinjyuku-ku, Tokyo

Tel

03-3353-1211

Email

med-rinri-jimu@adst.keio.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

慶應義塾大学病院(東京都)


Other administrative information

Date of disclosure of the study information

2021 Year 04 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

57

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2021 Year 02 Month 26 Day

Date of IRB

2021 Year 03 Month 30 Day

Anticipated trial start date

2021 Year 04 Month 08 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Prospective observational study. Patients who have been diagnosed with endometrial cancer, admitted to a research cooperation facility, and underwent radical surgery are included. Extract patient information (age, gender, medical history, treatment course, imaging test, etc.) from medical records. In addition, a self-administered questionnaire survey related to health-related QOL, ovarian deficiency symptoms, and physical activity will be conducted for the study subjects at three time points: after radical cure, 6 months and 12 months after surgery.


Management information

Registered date

2021 Year 04 Month 08 Day

Last modified on

2024 Year 04 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050068


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name